About Entrez
Text Version
Entrez PubMed
Overview
Help | FAQ
Tutorial
New/Noteworthy
E-Utilities
PubMed Services
Journals Database
MeSH Database
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
LinkOut
My
NCBI (Cubby)
Related Resources
Order Documents
NLM Catalog
NLM
Gateway
TOXNET
Consumer
Health
Clinical Alerts
ClinicalTrials.gov
PubMed
Central |
|
 |
|
-
A benfotiamine-vitamin B
combination in treatment of diabetic
polyneuropathy.
Stracke H, Lindemann A, Federlin
K.
Third Medical Department, University of Giessen,
Germany.
In a double-blind, randomized, controlled study, the
effectiveness of treatment with a combination of Benfotiamine (an
Allithiamine, a lipid-soluble derivative of vitamin B1 with high
bioavailability) plus vitamin B6/B12 on objective parameters of
neuropathy was studied over a period of 12 weeks on 24 diabetic patients
with diabetic polyneuropathy. The results showed a significant
improvement (p = 0.006) of nerve conduction velocity in the peroneal
nerve and a statistical trend toward improvement of the vibration
perception threshold. Long-term observation of 9 patients with verum
over a period of 9 months support the results. Therapy-specific adverse
effects were not seen. The results of this double-blind investigation,
of the long-term observation and of the reports in the literature
support the contention that the neurotropic benfotiamine-vitamin B
combination represents a starting point in the treatment of diabetic
polyneuropathy.
Publication Types:
- Clinical Trial
- Randomized Controlled Trial
PMID: 8886748 [PubMed -
indexed for MEDLINE]
|